NICE Guidance - October 2022
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of October 2022. This month there is one guideline and one technology appraisal that impact upon primary care.
The Osteoarthritis in over 16s: diagnosis and management guideline has been published. It covers the diagnosis, assessment and non-surgical management of osteoarthritis. It aims to improve management of osteoarthritis and the quality of life for people with osteoarthritis.
The SQ HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites technology appraisal has been terminated. NICE is unable to make a recommendation on this treatment because the manufacturer did not provide an evidence submission. The SPC notes that treatment should only be initiated by physicians with experience in treatment of allergic diseases.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
| « Drug Safety Update - October 2022 | CKS Updates - October 2022 » |
Leave a Comment